The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission

Burisch, J; Zhao, M; Odes, S; De Cruz, P; Vermeire, S; Bernstein, CN; Kaplan, GG; Duricova, D; Greenberg, D; Melberg, HO; Watanabe, M; Ahn, HS; Targownik, L; Pittet, VEH; Annese, V; Park, KT; Katsanos, KH; Hoivik, ML; Krznaric, Z; Chaparro, M; Loftus, EV ; Lakatos, PL; Gisbert, JP; Bemelman, W; Moum, B; Gearry, RB; Kappelman, MD; Hart, A; Pierik, MJ; Andrews, JM; Ng, SC; D'Inca, R; Munkholm, P

Burisch, J (通讯作者),Copenhagen Univ Hosp Amager & Hvidovre, Div Med, Gastro Unit, DK-2650 Hvidovre, Denmark.

LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023; 8 (5): 458

Abstract

The cost of caring for patients with inflammatory bowel disease (IBD) continues to increase worldwide. The cause is not only a steady increase in the ......

Full Text Link